ICU Medical Is Maintained at Overweight by Keybanc
KeyBanc Maintains ICU Medical(ICUI.US) With Buy Rating, Raises Target Price to $198
Jefferies Maintains ICU Medical(ICUI.US) With Hold Rating, Maintains Target Price $183
Jefferies Initiates ICU Medical(ICUI.US) With Hold Rating, Announces Target Price $183
ICU Medical Hold Rating Justified by Limited Growth Prospects and Premium Valuation
Needham Maintains ICU Medical(ICUI.US) With Hold Rating
ICU Medical Analyst Ratings
Needham Sticks to Its Hold Rating for ICU Medical (ICUI)
ICU Medical Is Maintained at Outperform by Raymond James
Raymond James Maintains ICU Medical(ICUI.US) With Buy Rating, Raises Target Price to $190
ICU Medical Analyst Ratings
Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $147
ICU Medical Analyst Ratings
ICU Medical (ICUI) Gets a Hold From Needham
KeyBanc Reaffirms Their Buy Rating on ICU Medical (ICUI)
ICU Medical Analyst Ratings
ICU Medical Analyst Ratings
Raymond James Upgrades ICU Medical to Outperform, Announces $135 Price Target
Analysts Are Bullish on These Healthcare Stocks: ICU Medical (ICUI), AbCellera Biologics (ABCL)
ICU Medical Analyst Ratings